Heather L. Shappell
About Heather L. Shappell
Heather L. Shappell is the Director of Policy Development and Market Access at BillionToOne, with over 20 years of experience in genetic counseling and clinical policy development. She has held various leadership roles in organizations such as the National Society of Genetic Counselors and Aetna, and has a strong background in molecular coding, billing, and reimbursement.
Current Role at BillionToOne
Heather L. Shappell serves as the Director of Policy Development, Market Access at BillionToOne since 2023. In this role, she focuses on developing policies that enhance market access for genetic testing services. Her expertise in molecular laboratory test coding, billing, and pricing supports her efforts in this capacity.
Previous Experience in Genetic Counseling
Heather has a diverse background in genetic counseling and health policy. She worked as the Director of Genetic Counseling at Generation Health, Inc. from 2009 to 2011. She also served as a Project Manager for the Prenatal Microarray Follow-Up Study at Columbia University from 2012 to 2014, and as a Precision Medicine Project Manager at Aetna from 2019 to 2021.
Educational Background
Heather earned a Master of Science in Genetic Counseling from the University of Pittsburgh, where she studied from 1997 to 1999. Additionally, she holds a Bachelor of Arts in Anthropology from Temple University, which she completed from 1992 to 1996. Her educational background supports her extensive knowledge in genetic counseling and related fields.
Leadership and Advisory Roles
Heather has held significant leadership roles, including serving on the Board of Directors for the National Society of Genetic Counselors from 2019 to 2020. She is also an invited member of the Centers for Medicare & Medicaid Services Advisory Panel on Clinical Diagnostic Laboratory Tests since 2019, contributing her expertise to national policy discussions.
Consulting and Independent Work
Heather has experience as an independent consultant, providing services in utilization management strategy for Medicare from 2021 to 2023. She has also been the Founder of InformedDNA since 2005, where she has contributed to the field of genetic counseling and policy development for nearly two decades.